Identity
- Security key
- 13917
- Ticker
- CURX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2025-08-26
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CURX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $6,410,447.51
- Shares outstanding (class)
- 28,364,812
- Shares outstanding (weighted)
- 28,364,812
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 6
- Location
- JERICHO, NY
- Homepage
- https://www.curanexpharma.com
- Description
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Market cap and share counts drift.